Michal Sarnecki

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

Lindsey R. Baden, Daniel J Stieh, Michal Sarnecki et al. · The Lancet HIV · 2020 · 90 citations · Full text

Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption

Donn Colby, Michal Sarnecki, Dan H. Barouch et al. · Nature Medicine · 2020 · 69 citations

Vaccination, Viral Persistence, Human Retrovirus +8

First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector

Lindsey R. Baden, Stephen R. Walsh, Michael S. Seaman et al. · The Journal of Infectious Diseases · 2018 · 45 citations · Full text

Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study

Daniel J Stieh, Dan H. Barouch, Christy Comeaux et al. · The Journal of Infectious Diseases · 2022 · 33 citations · Full text

Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis A vaccine in adults: A 20-year follow-up study

François Chappuis, T. Farinelli, H. Deckx et al. · Vaccine · 2017 · 30 citations

Vaccination, Vaccine Safety, Antibody Persistence +12